Impact of sarcopenia and myosteatosis on early and long-term survival after surgical resection of pancreatic ductal adenocarcinoma

Background - Sarcopenia and altered body composition are increasingly recognized as prognostic markers in oncology. In pancreatic ductal adenocarcinoma (PDAC), their time-dependent impact on survival remains unclear. - Methods - Patients with PDAC who underwent resection at Heidelberg University Hos...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Siegel, Niels (Autore) , Stollmayer, Róbert (Autore) , Mayer, Philipp (Autore) , Altendorf, Natalie (Autore) , Rompen, Ingmar F. (Autore) , König, Anna-Katharina (Autore) , Saeedi, Mohammed al (Autore) , Loos, Martin (Autore) , Büchler, Markus W. (Autore) , Klauß, Miriam (Autore) , Hank, Thomas (Autore)
Natura: Article (Journal)
Lingua:inglese
Pubblicazione: June 2026
In: Pancreatology
Year: 2026, Volume: 26, Fascicolo: 4, Pages: 627-634
ISSN:1424-3911
DOI:10.1016/j.pan.2026.04.007
Accesso online:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.pan.2026.04.007
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1424390326001493
Testo
Note sull'autore:Niels Siegel, Robert Stollmayer, Philipp Mayer, Natalie Altendorf, Ingmar F. Rompen, Anna-Katharina König, Mohammed Al-Saeedi, Martin Loos, Markus W. Büchler, Miriam Klauss, Thomas Hank
Descrizione
Riassunto:Background - Sarcopenia and altered body composition are increasingly recognized as prognostic markers in oncology. In pancreatic ductal adenocarcinoma (PDAC), their time-dependent impact on survival remains unclear. - Methods - Patients with PDAC who underwent resection at Heidelberg University Hospital between 2013 and 2018 were included. Preoperative CT scans were assessed at the L3 level using the automated Body and Organ Analysis (BOA) tool. Sarcopenia Index (SI) and Myosteatosis Fat Index (MFI) were calculated. Multivariable Cox regression was performed for overall survival at predefined postoperative time points. - Results - A total of 723 patients were included. Some 140 patients (19.4%) underwent neoadjuvant therapy, while 583 (80.6%) received upfront surgical resection. The median OS for the entire cohort was 26.0 months (95% CI, 23.4 - 28.3). Patients with a low SI exhibited markedly reduced overall survival compared to those with a high SI (p < 0.001). In multivariate Cox regression analyses, a lower SI was independently associated with increased mortality at 90 days (HR: 0.44, 95% CI: 0.24-0.81) and at 1 year (HR: 0.71, 95% CI: 0.56-0.90). A similar prognostic pattern was observed for the MFI, which also showed independent associations with early mortality. Beyond the first postoperative year, this effect diminished and nodal status, resection margin and CA19-9 levels became the predominant predictors of overall survival. - Conclusions - Preoperative sarcopenia and myosteatosis are strong predictors of early mortality after PDAC resection, whereas tumor biology determines long-term outcomes. Automated CT-based body composition analysis may support perioperative risk stratification and targeted prehabilitation strategies.
Descrizione del documento:Online verfügbar: 6. April 2026, Artikelversion: 4. Juni 2026
Gesehen am 21.08.2026
Descrizione fisica:Online Resource
ISSN:1424-3911
DOI:10.1016/j.pan.2026.04.007